Quick Answer
Nuo Therapeutics, Inc. reported Shares Outstanding of 48.18 million shares for fiscal year 2025.
Nuo Therapeutics, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 48.18M | +2.9% |
| 2024 | 46.82M | +5.8% |
| 2023 | 44.24M | +5.8% |
| 2022 | 41.80M | +12.6% |
| 2021 | 37.12M | +22.7% |
| 2021 | 30.26M | +0.0% |
| 2021 | 30.26M | +0.0% |
| 2021 | 30.26M | +0.0% |
| 2020 | 30.26M | +24.8% |
| 2020 | 24.25M | +0.0% |
| 2020 | 24.25M | +0.0% |
| 2020 | 24.25M | +2.2% |
| 2019 | 23.72M | +0.0% |
| 2018 | 23.72M | +4.4% |
| 2017 | 22.72M | +128.9% |
| 2016 | 9.93M | -92.1% |
| 2015 | 125.68M | +0.0% |
| 2014 | 125.68M | +17.3% |
| 2013 | 107.16M | +14.2% |
| 2012 | 93.81M | +68.9% |
| 2011 | 55.54M | +25.9% |
| 2010 | 44.10M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 47.88M | +2.8% | +2.3% |
| June 30, 2025 | 46.83M | +3.0% | +0.0% |
| March 31, 2025 | 46.82M | +5.8% | +0.0% |
| December 31, 2024 | 46.82M | +5.8% | +0.5% |
| September 30, 2024 | 46.60M | +10.1% | +2.5% |
| June 30, 2024 | 45.47M | +8.8% | +2.8% |
| March 31, 2024 | 44.24M | +5.8% | +0.0% |
| December 31, 2023 | 44.24M | +5.8% | +4.5% |
- Nuo Therapeutics, Inc. showed an increase of +2.9% in Shares Outstanding compared to the prior fiscal year.
- Over the 2010–2025 period, Nuo Therapeutics, Inc.’s shares outstanding has grown by 9.2% (from 44.10 million shares to 48.18 million shares).
- The most recent figure is from Nuo Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: